Oncostatin-M (OSM) is an IL-6 family inflammatory cytokine and plays a critical role in the development and progression of the underlying pathogenesis of atherosclerosis but the role of OSM in the context of plaque vulnerability and ECM remodeling has not been discussed in detail in the literature (Fig. 1). Here, OSM is linked to atherosclerosis.